Notch-1 regulates cell death independently of differentiation in murine erythroleukemia cells through multiple apoptosis and cell cycle pathways

2004 ◽  
Vol 199 (3) ◽  
pp. 418-433 ◽  
Author(s):  
Mei-Shiang Jang ◽  
Haixi Miao ◽  
Nadia Carlesso ◽  
Leslie Shelly ◽  
Andrei Zlobin ◽  
...  
1993 ◽  
Vol 13 (1) ◽  
pp. 711-719
Author(s):  
J J Ryan ◽  
R Danish ◽  
C A Gottlieb ◽  
M F Clarke

A temperature-sensitive mutant of murine p53 (p53Val-135) was transfected by electroporation into murine erythroleukemia cells (DP16-1) lacking endogenous expression of p53. While the transfected cells grew normally in the presence of mutant p53 (37.5 degrees C), wild-type p53 (32.5 degrees C) was associated with a rapid loss of cell viability. Genomic DNA extracted at 32.5 degrees C was seen to be fragmented into a characteristic ladder consistent with cell death due to apoptosis. Following synchronization by density arrest, transfected cells released into G1 at 32.5 degrees C were found to lose viability more rapidly than did randomly growing cultures. Following release into G1, cells became irreversibly committed to cell death after 4 h at 32.5 degrees C. Commitment to cell death correlated with the first appearance of fragmented DNA. Synchronized cells allowed to pass out of G1 prior to being placed at 32.5 degrees C continued to cycle until subsequently arrested in G1; loss of viability occurred following G1 arrest. In contrast to cells in G1, cells cultured at 32.5 degrees C for prolonged periods during S phase and G2/M, and then returned to 37.5 degrees C, did not become committed to cell death. G1 arrest at 37.5 degrees C, utilizing either mimosine or isoleucine deprivation, does not lead to rapid cell death. Upon transfer to 32.5 degrees C, these G1 synchronized cell populations quickly lost viability. Cells that were kept density arrested at 32.5 degrees C (G0) lost viability at a much slower rate than did cells released into G1. Taken together, these results indicate that wild-type p53 induces cell death in murine erythroleukemia cells and that this effect occurs predominantly in the G1 phase of actively cycling cells.


Blood ◽  
2000 ◽  
Vol 96 (8) ◽  
pp. 2755-2764 ◽  
Author(s):  
Igor Matushansky ◽  
Farshid Radparvar ◽  
Arthur I. Skoultchi

Abstract Terminal differentiation of erythroid cells results in terminal cell divisions followed by irreversible cell cycle withdrawal of hemoglobinized cells. The mechanisms leading to cell cycle withdrawal were assessed in stable transfectants of murine erythroleukemia cells, in which the activities of cyclin-dependent kinases (CDKs) and CDK inhibitors (CDKIs) could be tightly regulated during differentiation. Cell cycle withdrawal of differentiating cells is mediated by induction of several CDKIs, thereby leading to inhibition of CDK2 and CDK4. Manipulation of CDK activity in differentiating cells demonstrates that the onset of cell cycle withdrawal can be either greatly accelerated or greatly delayed without affecting hemoglobin levels. Extending the proliferation of differentiating cells requires the synergistic action of CDK2 and CDK4. Importantly, CDK6 cannot substitute for CDK4 in this role, which demonstrates that the 2 cyclin D–dependent kinases are functionally different. The results show that differentiating hemoglobinized cells can be made to proliferate far beyond their normal capacity to divide.


Blood ◽  
2000 ◽  
Vol 96 (8) ◽  
pp. 2755-2764 ◽  
Author(s):  
Igor Matushansky ◽  
Farshid Radparvar ◽  
Arthur I. Skoultchi

Terminal differentiation of erythroid cells results in terminal cell divisions followed by irreversible cell cycle withdrawal of hemoglobinized cells. The mechanisms leading to cell cycle withdrawal were assessed in stable transfectants of murine erythroleukemia cells, in which the activities of cyclin-dependent kinases (CDKs) and CDK inhibitors (CDKIs) could be tightly regulated during differentiation. Cell cycle withdrawal of differentiating cells is mediated by induction of several CDKIs, thereby leading to inhibition of CDK2 and CDK4. Manipulation of CDK activity in differentiating cells demonstrates that the onset of cell cycle withdrawal can be either greatly accelerated or greatly delayed without affecting hemoglobin levels. Extending the proliferation of differentiating cells requires the synergistic action of CDK2 and CDK4. Importantly, CDK6 cannot substitute for CDK4 in this role, which demonstrates that the 2 cyclin D–dependent kinases are functionally different. The results show that differentiating hemoglobinized cells can be made to proliferate far beyond their normal capacity to divide.


2010 ◽  
Vol 1798 (9) ◽  
pp. 1797-1804 ◽  
Author(s):  
Patrick Constantinescu ◽  
Bin Wang ◽  
Kati Kovacevic ◽  
Iman Jalilian ◽  
Giel J.C.G.M. Bosman ◽  
...  

1991 ◽  
Vol 73 (2-3) ◽  
pp. 36a-36a
Author(s):  
Didier GRUNWALD ◽  
Saadi KHOCHBIN ◽  
Jean-Jacques LAWRENCE

1995 ◽  
Vol 16 (8) ◽  
pp. 1761-1767 ◽  
Author(s):  
Nina Fukunaga-Johnson ◽  
James J. Rayn ◽  
Max Wicha ◽  
Gabriel Nuñez ◽  
Michael F. Clarke

Cytometry ◽  
1992 ◽  
Vol 13 (5) ◽  
pp. 518-524 ◽  
Author(s):  
Fabienne Mencherini ◽  
Saadi Khochbin ◽  
Agnès Chabanas ◽  
Jean-Jacques Lawrence

Sign in / Sign up

Export Citation Format

Share Document